[18F]GEH121224
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]GEH121224, covering 2025-10-23 to 2025-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1]